Final Data from the Phase 2 COSMOS Study of Janssen’s Once-Daily Simeprevir in Combination with Sofosbuvir Presented at The International Liver Congress™ 2014 of the European Association for the Study of the Liver (EASL)
- EMEA Innovative Medicine
- Final Data from Phase 2 COSMOS Study of Simeprevir in Combination with Sofosbuvir
Final Data from Phase 2 COSMOS Study of Simeprevir in Combination with Sofosbuvir
- X (Twitter)
Copy link